1. Purifying selection decreases the potential for Bangui orthobunyavirus outbreaks in humans.
- Author
-
Orf GS, Perez LJ, Meyer TV, Luk KC, Forberg K, Rodgers MA, Hadji A, James L, Mampunza S, Achari A, Yu G, Federman S, Chiu CY, McArthur CA, Cloherty GA, and Berg MG
- Abstract
Pathogens carried by insects, such as bunyaviruses, are frequently transmitted into human populations and cause diseases. Knowing which spillover events represent a public health threat remains a challenge. Metagenomic next-generation sequencing (mNGS) can support infectious disease diagnostics by enabling the detection of any pathogen from clinical specimens. mNGS was performed on blood samples to identify potential viral coinfections in human immunodeficiency virus (HIV)-positive individuals from Kinshasa, the Democratic Republic of the Congo (DRC), participating in an HIV diversity cohort study. Time-resolved phylogenetics and molecular assay development assisted in viral characterization. The nearly complete genome of a novel orthobunyavirus related to Nyangole virus, a virus previously identified in neighboring Uganda, was assembled from a hepatitis B virus-positive patient. A quantitative polymerase chain reaction assay was designed and used to screen >2,500 plasma samples from Cameroon, the DRC, and Uganda, failing to identify any additional cases. The recent sequencing of a US Center for Disease Control Arbovirus Reference Collection revealed that this same virus, now named Bangui virus, was first isolated in 1970 from an individual in the Central African Republic. Time-scaled phylogenetic analyses of Bangui with the related Anopheles and Tanga serogroup complexes indicate that this virus emerged nearly 10,000 years ago. Pervasive and episodic models further suggest that this virus is under purifying selection and that only distant common ancestors were subject to positive selection events. This study represents only the second identification of a Bangui virus infection in over 50 years. The presumed rarity of Bangui virus infections in humans can be explained by its constraint to an avian host and insect vector, precluding efficient transmission into the human population. Our results demonstrate that molecular phylogenetic analyses can provide insights into the threat posed by novel or re-emergent viruses identified by mNGS., Competing Interests: G.S.O., L.J.P., T.V.M., K.-C.L., K.F., M.A.R., G.A.C., and M.G.B. are all employees and shareholders of Abbott Laboratories. C.Y.C. is the Director of the University of California San Francisco (UCSF)-Abbott Viral Diagnostics and Discovery Center and received research support from Abbott Laboratories for pathogen discovery. The remaining authors do not have conflicts of interest to disclose. No patents have been applied for, and no products are in development related to this research., (© The Author(s) 2023. Published by Oxford University Press.)
- Published
- 2023
- Full Text
- View/download PDF